Skip to content

Correlation between symmetrical polyneuropathy of type 2 diabetes mellitus and serum 25 hydroxyvitamin D

Correlation between symmetrical polyneuropathy of type 2 diabetes mellitus and serum 25 hydroxyvitamin D

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062252
Enrollment
Unknown
Registered
2022-07-31
Start date
2022-07-31
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Type 2 diabetes asymptomatic peripheral neuropathy group:None
Type 2 diabetes symptomatic peripheral neuropathy group:None
Type 2 diabetes without peripheral neuropathy group:None

Sponsors

Longyan First Hospital Affiliated to Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged >=18 years who have been diagnosed with type 2 diabetes according to the 1999 World Health Organization diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. Vitamin D therapy within the last month; 2. Parathyroid diseases and osteoporosis; 3. Chronic alcohol intoxication; 4. Patients with hyperthyroidism or hypothyroidism; 5. Severe disability or mental illness; 6. Pregnant and lactating patients; 7. Patients with myocardial infarction, angina pectoris, stroke and other peripheral vascular diseases; 8. Stress diseases such as shortness of breath, chest pain, electrolyte disturbance, fever, diarrhea and other acute inflammation; 9. Organic diseases such as tumor and severe liver and kidney insufficiency; 10. Stress hyperglycemia, hyperglycemia caused by hormones and other drugs; 11. Patients with diabetic ketoacidosis, hypertonic syndrome, hypoglycemia and other non-homeostasis.

Design outcomes

Primary

MeasureTime frame
25 hydroxyvitamin D;Michigan neuropathy screening instrument;

Secondary

MeasureTime frame
Toronto clinical scoring system;Fasting plasma glucose;Postprandial blood glucose;Glycosylated hemoglobin;Fasting C-peptide;Uric acid;Triglycerides;Total cholesterol;High-density lipoprotein cholesterol;Low density lipoprotein cholesterol;Blood calcium;Waist circumference;Hip circumference;Calf circumference;Systolic blood pressure;Diastolic blood pressure;Parathyroid hormone;Urinary albumin creatinine ratio;Serum albumin;Serum creatinine;

Countries

China

Contacts

Public ContactChen Tao

Longyan First Hospital Affiliated to Fujian Medical University

citycreek@163.com+86 13859206278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026